Construction of A Nomogram Prediction Model for PD-L1 Expression in Non-small Cell Lung Cancer Based on 18F-FDG PET/CT Metabolic Parameters
Background and objective In recent years, immunotherapy represented by programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) immunosuppressants has greatly changed the status of non-small cell lung cancer (NSCLC) treatment. PD-L1 has become an important biomarker for screening NSCLC...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Chinês |
| Опубликовано: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2023-11-01
|
| Серии: | Chinese Journal of Lung Cancer |
| Предметы: | |
| Online-ссылка: | http://dx.doi.org/10.3779/j.issn.1009-3419.2023.101.32 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|